A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

NCT00283465 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Neoplasm

Interventions

DRUG: Epoetin alfa

Sponsor

Janssen-Cilag B.V.